Companies: 10,795·Total market cap: $144.5T
Ingevity Corporation

Ingevity Corporation

NGVTNYSEBasic Materials● Active
$66.45
+$0.46(+0.70%)
Market Cap$2.3B
P/E Ratio
52W High$79.29
52W Low$39.74
Overview

Ingevity Corporation (NGVT) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ngvt · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
3
Sell
0
Strong Sell
0
Total: 13 · Buy rate: 76.9%

12-Month Price Target

High

$83.00

Consensus

$76.67

+15.4% upside

Low

$65.00

Median: $82 · Last Close: $66.45

The Ingevity Corporation (NGVT) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month NGVT price target is $76.67, representing +15.4% upside from the current price of $66.45.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $77 (15.4%)

Consensus Target

$76.67

15.4% upside

High Target

$83

24.9%

Low Target

$65

-2.2%

Current Price

$66.45

as of today

Based on analyst price targets, the NGVT stock price prediction for the next 12 months ranges from $65 to $83. The consensus NGVT price forecast of $76.67 implies 15.4% upside from the current price of $66.45.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$65.491.45%

1-day model range: $65.21–$65.77. Peak: $65.77 (-1.45%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$63-4.7%
2028$62-7.3%
2029$61-8.9%
2030$60-9.8%
2031-10.4%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)49.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NGVT · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$66.53SELL
MA 10$67.31SELL
MA 20$67.94SELL
MA 50$71.69SELL
MA 100$70.39SELL
MA 200$63.10BUY
Current $NGVT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$66.53SELL
EMA 10$67.03SELL
EMA 20$68.28SELL
EMA 50$69.78SELL
EMA 100$68.32SELL
EMA 200$63.49BUY
Current $NGVT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Wells Fargo2026-02-27
Maintains
Equal WeightEqual Weight
Wells Fargo2026-01-29
Maintains
Equal WeightEqual Weight
Wells Fargo2025-12-19
Maintains
Equal WeightEqual Weight
BMO Capital2025-12-10
Maintains
OutperformOutperform
Wells Fargo2025-11-12
Maintains
Equal WeightEqual Weight
BMO Capital2025-09-05
Maintains
OutperformOutperform
BMO Capital2025-08-07
Maintains
OutperformOutperform
Wells Fargo2025-07-14
Maintains
Equal WeightEqual Weight
Wells Fargo2025-05-07
Maintains
Equal WeightEqual Weight
Wells Fargo2025-04-09
Maintains
Equal WeightEqual Weight

Wall Street analysts have recently issued updated ratings on Ingevity Corporation (NGVT) stock. Of the recent 85 rating actions, 10 were upgrades and 7 were downgrades. 13 analysts currently cover NGVT.

Analyst Recommendation Trends

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

NGVT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1.4B

↑ 28.7% YoY

Revenue Next Year

$1.2B

↓ 11.6% YoY

EPS This Year

$2.93

EPS Next Year

$4.46

↑ 52.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NGVT EPS of $2.93 for the current fiscal year, based on estimates from 2 analysts. The NGVT revenue forecast is $1.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NGVT stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NGVT price target is $76.67 (+15.4% upside), with an analyst consensus of Buy.

The NGVT short-term stock prediction for tomorrow is $65.49 (-1.45%). The NGVT stock price prediction for 2027 estimates an average of $63. The NGVT stock prediction for 2030 projects a range of $57–$63.

Ingevity Corporation trades on NYSE under the ticker NGVT. The NGVT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 77% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NGVT forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month NGVT price target is $76.67, with a high forecast of $83.00 and a low of $65.00. The median price target is shown in the chart above when available. This implies +15.4% potential upside from the current price of $66.45.

NGVT price targetWhat is NGVT price targetNGVT analyst price targetNGVT 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.